News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Daily News Patchy Anticoagulation Use During COVID Pandemic Raises Questions L.A. McKeown March 06, 2025
News Daily News IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication L.A. McKeown December 03, 2024
News Conference News TCT 2024 PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE Todd Neale October 29, 2024
News Conference News ISET 2024 AI in Pulmonary Embolism: ‘Transformative’ for Patient Care Caitlin E. Cox January 30, 2024
News Daily News High-Sensitivity Troponins May Overestimate PE Severity L.A. McKeown November 28, 2023
News Conference News ESC 2023 ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients L.A. McKeown August 30, 2023
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty Todd Neale August 25, 2022
News Daily News Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients L.A. McKeown June 29, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News AHA 2021 Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded L.A. McKeown November 18, 2021
News Conference News TCT 2021 FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results Todd Neale November 03, 2021